AMRN Amarin Corp PLC ADRs

Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The Company is engaged in commercialization and development of therapeutics to improve cardiovascular health. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$5.15  -0.02 (-0.39%)
As of 09/17/2021 15:59:36 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  United Kingdom
Country of incorporation:  United Kingdom
IPO date:  02/05/2001
Outstanding shares:  395,302,404
Average volume:  3,100,420
Market cap:   $2,039,760,405
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    023111206
ISIN:        US0231112063
Sedol:      2301938
Valuation   (See tab for details)
PE ratio:   473.10
PB ratio:   3.17
PS ratio:   3.29
Return on equity:   0.67%
Net income %:   0.70%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy